When Should CAR-T Therapy Be Considered for Relapsed/Refractory DLBCL Patients?
When Should CAR-T Therapy Be Considered for Relapsed/Refractory DLBCL Patients? from Patient Empowerment Network on Vimeo. When can relapsed/refractory diffuse large B-cell lymphoma (DLBCL) patients benefit from CAR T-cell therapy? […]